ArticleBreast cancer research and treatment2014

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies.

Siamak SabourPubMed ↗Publisher ↗

No numbers read from the abstract.